Elizabeth Kwo - Net Worth and Insider Trading
Elizabeth Kwo Net Worth
The estimated net worth of Elizabeth Kwo is at least $25,119 dollars as of 2024-11-13. Elizabeth Kwo is the Director of Asensus Surgical Inc and owns about 72,201 shares of Asensus Surgical Inc (ASXC) stock worth over $25,119. Details can be seen in Elizabeth Kwo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elizabeth Kwo has not made any transactions after 2022-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elizabeth Kwo
Elizabeth Kwo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elizabeth Kwo owns 2 companies in total, including Flexion Therapeutics Inc (FLXN) , and Asensus Surgical Inc (ASXC) .
Click here to see the complete history of Elizabeth Kwo’s form 4 insider trades.
Insider Ownership Summary of Elizabeth Kwo
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FLXN | Flexion Therapeutics Inc | 2020-08-18 | director |
ASXC | Asensus Surgical Inc | 2022-03-15 | director |
Elizabeth Kwo Latest Holdings Summary
Elizabeth Kwo currently owns a total of 1 stock. Elizabeth Kwo owns 72,201 shares of Asensus Surgical Inc (ASXC) as of March 15, 2022, with a value of $25,119.
Latest Holdings of Elizabeth Kwo
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ASXC | Asensus Surgical Inc | 2022-03-15 | 72,201 | 0.35 | 25,119 |
Holding Weightings of Elizabeth Kwo
Elizabeth Kwo Form 4 Trading Tracker
According to the SEC Form 4 filings, Elizabeth Kwo has made a total of 1 transactions in Asensus Surgical Inc (ASXC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Asensus Surgical Inc is the acquisition of 18,000 shares on March 15, 2022, which cost Elizabeth Kwo around $9,540.
Insider Trading History of Elizabeth Kwo
- 1
Elizabeth Kwo Trading Performance
GuruFocus tracks the stock performance after each of Elizabeth Kwo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Elizabeth Kwo is -26.79%. GuruFocus also compares Elizabeth Kwo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Elizabeth Kwo within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Elizabeth Kwo's insider trading performs compared to the benchmark.
Performance of Elizabeth Kwo
Elizabeth Kwo Ownership Network
Ownership Network List of Elizabeth Kwo
Ownership Network Relation of Elizabeth Kwo
Elizabeth Kwo Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
Elizabeth Kwo is the director of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , General Counsel Mark S. Levine , and Chief Strategy Officer Christina Willwerth .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
Elizabeth Kwo Mailing Address
Above is the net worth, insider trading, and ownership report for Elizabeth Kwo. You might contact Elizabeth Kwo via mailing address: C/o Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington Ma 01803.